Physician profile
Anna Young
NPI 1083854947
$1,220.15
in general payments reported to CMS, 2019-2025
14 companies · $486 in 2025
The $486 reported for 2025 was more than what 78% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $74.03 · 2021: $42.39 · 2022: $17.34 · 2024: $255 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $288.14 | 2024-2025 | |
| Smith+Nephew, INC. | $149.60 | 2019-2024 | Collagenase Santyl |
| Kerecis Limited | $118.26 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $117.96 | 2024-2025 | Nuzyra |
| Terumo Medical Corporation | $116.99 | 2019 | |
| Organogenesis INC. | $111.29 | 2019-2024 | |
| Kci USA, INC. | $97.55 | 2019-2021 | |
| Tactile Systems Technology INC | $67.14 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Solventum Corporation | $57.40 | 2024-2025 | Activ.A.C., V.A.C. Dermatac, Snap |
| Hydrofera LLC | $25.49 | 2025 | Hydrofera Blue |
| Convatec INC. | $22.40 | 2025 | |
| Aroa Biosurgery Incorporated | $17.34 | 2022 | |
| Merck Sharp & Dohme LLC | $15.37 | 2019 | |
| Reprise Biomedical, INC. | $15.22 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.